Documentos federales recientes

{
  "data": {
    "count": 10000,
    "documents": [
      {
        "abstract": null,
        "agencies": [
          "Executive Office of the President"
        ],
        "document_number": "2026-18046",
        "html_url": "https://www.federalregister.gov/documents/2026/09/02/2026-18046/continuation-of-the-national-emergency-with-respect-to-foreign-interference-in-or-undermining-public",
        "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2026-09-02/pdf/2026-18046.pdf",
        "publication_date": "2026-09-02",
        "title": "Continuation of the National Emergency With Respect to Foreign Interference in or Undermining Public Confidence in United States Elections",
        "type": "Presidential Document"
      },
      {
        "abstract": null,
        "agencies": [
          "Executive Office of the President"
        ],
        "document_number": "2026-18020",
        "html_url": "https://www.federalregister.gov/documents/2026/09/02/2026-18020/honoring-the-american-history-of-the-great-lakes-and-renaming-lake-ontario-as-lake-america",
        "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2026-09-02/pdf/2026-18020.pdf",
        "publication_date": "2026-09-02",
        "title": "Honoring the American History of the Great Lakes and Renaming Lake Ontario as Lake America",
        "type": "Presidential Document"
      },
      {
        "abstract": "The National Institute of Diabetes and Digestive and Kidney Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the invention embodied in the patents and patent applications listed in the Supplementary Information section of this notice to Nulyn Science (\"Nulyn\"), a company located in Paris, France.",
        "agencies": [
          "Health and Human Services Department",
          "National Institutes of Health"
        ],
        "document_number": "2026-17991",
        "html_url": "https://www.federalregister.gov/documents/2026/09/02/2026-17991/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-mifepristone",
        "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2026-09-02/pdf/2026-17991.pdf",
        "publication_date": "2026-09-02",
        "title": "Prospective Grant of an Exclusive Patent License: Development and Commercialization of Mifepristone and Analogues To Treat Hypercortisolism-Related Insulin Resistance Disorders",
        "type": "Notice"
      },
      {
        "abstract": "The U.S. Small Business Administration (SBA) is publishing for public comment updated minimum performance standards for commercialization for firms funded through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. This commercialization benchmark establishes a minimum share of annual revenue that a Small Business Concern (SBC) must derive from sources other than SBIR or STTR program funding in order to remain eligible for a new Phase I or Direct-to-Phase II award, where that SBC has received more than 25 Phase II awards during the five most recently completed fiscal years, excluding the current fiscal year. The revised benchmark will supersede the benchmark announced at 78 FR 48537 and 78 FR 59410. This requirement is issued under the authority of Section 9 of the Small Business Act.",
        "agencies": [
          "Small Business Administration"
        ],
        "document_number": "2026-17987",
        "html_url": "https://www.federalregister.gov/documents/2026/09/02/2026-17987/updated-minimum-performance-standards-for-commercialization-for-firms-that-receive-funding-through",
        "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2026-09-02/pdf/2026-17987.pdf",
        "publication_date": "2026-09-02",
        "title": "Updated Minimum Performance Standards for Commercialization for Firms That Receive Funding Through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs",
        "type": "Notice"
      },
      {
        "abstract": "The Environmental Protection Agency (EPA) is providing notification of its final action entitled August 31, 2026 Decision on Petitions for RFS Small Refinery Exemptions (\"August 31, 2026 SRE Decisions Action\") in which EPA issued decisions on 34 small refinery exemption (SRE) petitions under the Renewable Fuel Standard (RFS) program for the 2025 compliance year. EPA is also reissuing a decision for 1 petition for the 2024 compliance year that was originally issued in the August 3, 2026 Decision on Petitions for RFS Small Refinery Exemptions. EPA is providing this notification for public awareness of, and the basis for, EPA's decision announced on August 31, 2026.",
        "agencies": [
          "Environmental Protection Agency"
        ],
        "document_number": "2026-17985",
        "html_url": "https://www.federalregister.gov/documents/2026/09/02/2026-17985/notice-of-august-31-2026-decisions-on-petitions-for-small-refinery-exemptions-under-the-renewable",
        "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2026-09-02/pdf/2026-17985.pdf",
        "publication_date": "2026-09-02",
        "title": "Notice of August 31, 2026 Decisions on Petitions for Small Refinery Exemptions Under the Renewable Fuel Standard Program",
        "type": "Notice"
      }
    ],
    "total_pages": 50
  },
  "success": true
}